Key result
Coronary risk factors in Turkish CAD patients included a 65% smoking prevalence, while prophylactic drug usage at discharge (e.g., 99% antiplatelets) was higher than the European average.
Cross-Sectional (n=617)
No
In Turkish patients with angiographically proven CAD, smoking rates were higher while hypertension, hyperlipidemia, and family history were lower compared to European averages, alongside high rates of prophylactic drug usage at discharge.
High smoking rates in Turkish CAD patients signal prevention gaps; cross-sectional data leaves open whether regional patterns warrant tailored guidelines or outcome studies.
BACKGROUND: Coronary artery disease (CAD) is the leading cause of adult deaths in our country. In clinical practice, an adequate level of secondary prevention towards CAD primarily requires full recognition of the distribution of risk factors. The aim of our study was to determine the prevalence of coronary risk factors and the use of prophylactic drugs among patients who have an angiographically proven CAD in our centre, and to compare it with those of the EUROASPIRE I and II studies. DESIGN: Cross-sectional, observational study. METHODS: Our patients comprise 617 subjects (516 male, mean age 57.2 +/- 10.8 years) who underwent an angiography between January 2000 and May 2000 for the first time and in whom significant coronary lesions were detected. Age, gender, family history of premature CAD (FH), diabetes mellitus (DM), hypertension (HT), lipid profile, smoking, body mass index, waist circumference, hip circumference and physical activity data were recorded prior to angiography. The medical treatments received by these cases at discharge from hospital were investigated. Data thus obtained were compared with the results of the EUROASPIRE I and II trials, which studied the frequency of existing risk factors and prophylactic drug use among CAD patients in European countries. RESULTS: Hyperlipidaemia, FH, DM, HT, smoking, obesity, central obesity were found in 52, 26, 20, 41, 65, 18 and 29% of patients, respectively. The use of antiplatelets, beta-blockers, ACE inhibitors, statins and calcium antagonists were 99, 86, 40, 63 and 16%, respectively. CONCLUSION: Upon comparison of the risk factors, prevalence of obesity and DM was found to be similar to the average of nine European countries among our subjects. Smoking was found to be considerably higher, whereas HT, hyperlipidaemia and family history of premature CAD were lower than the European average within our subjects. In our cases the frequency of prophylactic drug usage at discharge was higher than the European means.
No takes yet. Share an insight, caveat, or question.
Sönmez et al. (2002) conducted a cross-sectional in Coronary artery disease (n=617). Coronary risk factors and prophylactic drug usage vs. EUROASPIRE I and II studies (European average) was evaluated on Prevalence of coronary risk factors and prophylactic drug use. Coronary risk factors in Turkish CAD patients included a 65% smoking prevalence, while prophylactic drug usage at discharge (e.g., 99% antiplatelets) was higher than the European average.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: